-This post applies to just the rarest of circumstances and does not implicate the well established safety of IFN as we use it. -
I've been checking out trials etc for Sjogren's for obvious reasons. I came across this one which has a clearly presented note on the IFN-autoimmune connection I've posted on. This IFN is the type 1 we take, but it's of a sort created within the body, so not the medical version if there is a difference.
But it does illustrate my experience that if you're tipping to a concerning immune condition, adding more IFN is contra indicated. This therapy is specifically looking to reduce systemic IFN as an end point.
My real life example is that "last IFN dose" that clearly tipped me to the abyss.
In practice I think this supports the "lowest effective IFN dose" strategy that many members are already doing. (and I didn't)
(I plan inquire on this trial)